EP 1572646 A1 20050914 - N-(INDOLETHYL-)CACLOAMINE COMPOUNDS
Title (en)
N-(INDOLETHYL-)CACLOAMINE COMPOUNDS
Title (de)
N-(INDOLETHYL-)CYCLOAMIN-VERBINDUNGEN
Title (fr)
COMPOSÉS DE N-(INDOLETHYL-)CYCLOAMINE
Publication
Application
Priority
- DE 10259244 A 20021217
- EP 0313374 W 20031127
Abstract (en)
[origin: WO2004054972A1] The invention relates to n-(indolethyl-)cacloamine compounds of a formula (i), wherein R<1>, R<1> x, Ar and n have a meaning of the claim 1. The inventive compounds consist of inhibitors of serotonin recapture (SSRI) and activators of serotoninenergic receptors 5-HT1A and 5-HT2A. Said compounds are used for preventing and treating various diseases of the central nervous system such as depression, dyskenesia, Parkinson's disease, dementia, vascular cerebral accident, schizophrenia, Alzheimer disease, Lewy bodies dementia, Huntington disease, Gille de la Tourette syndrome, anxiety, learning difficulties, memory disorder, pain, insomnia and neurodegenerative diseases.
IPC 1-7
C07D 209/14; A61K 31/404; A61P 43/00; C07D 209/42; C07D 405/12; C07D 417/12; A61K 31/495
IPC 8 full level
A61P 43/00 (2006.01); C07D 209/14 (2006.01); C07D 209/18 (2006.01); C07D 209/42 (2006.01); C07D 405/12 (2006.01); C07D 417/12 (2006.01)
CPC (source: EP KR US)
A61P 9/10 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 25/04 (2017.12 - EP); A61P 25/14 (2017.12 - EP); A61P 25/16 (2017.12 - EP); A61P 25/18 (2017.12 - EP); A61P 25/20 (2017.12 - EP); A61P 25/22 (2017.12 - EP); A61P 25/24 (2017.12 - EP); A61P 25/28 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07D 209/14 (2013.01 - EP KR US); C07D 209/18 (2013.01 - EP US); C07D 209/42 (2013.01 - EP US); C07D 401/06 (2013.01 - KR); C07D 405/12 (2013.01 - EP US); C07D 405/14 (2013.01 - KR); C07D 417/12 (2013.01 - EP US)
Citation (search report)
See references of WO 2004054972A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2004054972 A1 20040701; AU 2003298145 A1 20040709; BR 0317422 A 20051108; CA 2510169 A1 20040701; CN 1729173 A 20060201; DE 10259244 A1 20040701; EP 1572646 A1 20050914; JP 2006511522 A 20060406; KR 20050085697 A 20050829; MX PA05006385 A 20050829; PL 377519 A1 20060206; RU 2005122615 A 20060120; US 2006122191 A1 20060608; ZA 200505684 B 20060426
DOCDB simple family (application)
EP 0313374 W 20031127; AU 2003298145 A 20031127; BR 0317422 A 20031127; CA 2510169 A 20031127; CN 200380106737 A 20031127; DE 10259244 A 20021217; EP 03795848 A 20031127; JP 2004559727 A 20031127; KR 20057011051 A 20050616; MX PA05006385 A 20031127; PL 37751903 A 20031127; RU 2005122615 A 20031127; US 53951605 A 20050617; ZA 200505684 A 20050714